<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7441762\results\search\disease\results.xml">
  <result pre="a prophylactic measure due to its cardiotoxicity. There is an" exact="acute" post="requirement for a drug candidate that has significant clinical"/>
  <result pre="molecules that could inhibit SARS-CoV-2 at different stages of its" exact="infectious" post="cycle. Several in silico studies on natural derivatives, especially"/>
  <result pre="as potential drug candidates that bind efficiently with the key" exact="viral" post="proteins. However, oral bioavailability of these nutriments is considerably"/>
  <result pre="digestion in the gastrointestinal tract. Here we discuss few natural" exact="secondary" post="metabolites (Delphinidin 3,5-diglucoside, Scutellarein 7-glucoside, Avicularin and 3,5-Di-O-galloylshikimic acid)"/>
  <result pre="having a place in the Coronaviridae family and they cause" exact="respiratory" post="tract infections in humans, animals and birds. SARS-like CoVs"/>
  <result pre="place in the Coronaviridae family and they cause respiratory tract" exact="infections" post="in humans, animals and birds. SARS-like CoVs isolated from"/>
  <result pre="them to directly infect humans without any requirement for an" exact="intermediate" post="host (Hu etÂ al., 2018). The genome of SARS"/>
  <result pre="of SARS-CoV-2 spike protein (Zhang etÂ al., 2020). Among several" exact="viral" post="proteins, the main protease of SARS-Cov2 (Mpro) is more"/>
  <result pre="of RdRp and antimalarial drug chloroquine effectively inhibited the SARS-CoV-2" exact="infection" post="inÂ vitro (M. Wang etÂ al., 2020). Hydroxychloroquine, an"/>
  <result pre="both blocker of receptor mediated host cell uptake of the" exact="viral" post="particles and inhibitor of the viral replication. In this"/>
  <result pre="cell uptake of the viral particles and inhibitor of the" exact="viral" post="replication. In this direction, we have selected two target"/>
  <result pre="have low bioavailability. Material and methods Target selection We selected" exact="viral" post="and host targets, SARS CoV-2 main protease (Mpro) and"/>
  <result pre="respectively. Position of N3 and MLN-4760 was set as the" exact="primary" post="active site for the docking of selected ligands. The"/>
  <result pre="similar cleavage site making it an interesting antiviral target with" exact="lower" post="probability of inhibitor toxicity. While human ACE2 belongs to"/>
  <result pre="inhibitor toxicity. While human ACE2 belongs to the category of" exact="type I" post="integral membrane protein having 805 amino acids. Despite its"/>
  <result pre="principle inhibitory mechanism takes place inside the host cell where" exact="viral" post="replication unfolds. The possibility for these molecules to bind"/>
  <result pre="these molecules to bind to offâ€&quot;target proteins that are of" exact="viral" post="or host origin cannot be ruled out. Recently FDA"/>
  <result pre="triphosphate (ATP) analog, GS-441524 that interferes with the action of" exact="viral" post="RNA-dependent RNA polymerase towards controlling viral RNA production. From"/>
  <result pre="with the action of viral RNA-dependent RNA polymerase towards controlling" exact="viral" post="RNA production. From the present study, the estimated docking"/>
  <result pre="and Figure 2 (ii) and (iii). Among the 30 natural" exact="secondary" post="metabolites screened, the top four leads exhibiting highest binding"/>
  <result pre="docking poses (GuimarÃ£es &amp;amp; Cardozo, 2008). All these four natural" exact="secondary" post="metabolites were found to fit perfectly at the active"/>
  <result pre="of this anthocyanin as an anticancer agent against colon and" exact="fibrosarcoma" post="cancer. One of them reported that it significantly inhibited"/>
  <result pre="that it significantly inhibited the HCT 116 and HT-29 human" exact="colon cancer" post="cells (Mazewski etÂ al., 2019). In another study, delphinidin-3,5-glucoside"/>
  <result pre="it significantly inhibited the HCT 116 and HT-29 human colon" exact="cancer" post="cells (Mazewski etÂ al., 2019). In another study, delphinidin-3,5-glucoside"/>
  <result pre="n.d.). Avicularin elevated the sensitivity of cisplatin in drug resistant" exact="gastric cancer" post="cells in inÂ vitro and inÂ vivo studies by"/>
  <result pre="Avicularin elevated the sensitivity of cisplatin in drug resistant gastric" exact="cancer" post="cells in inÂ vitro and inÂ vivo studies by"/>
  <result pre="(Figure 4(iv)). The docking score of all the screened natural" exact="secondary" post="metabolites is shown in Figure 5. Figure 5. Docking"/>
  <result pre="2005). With ABS-0.17, delphinidin 3,5-diglucoside (an anthocyanin), the bioavailability through" exact="gastro" post="intestinal tract (GIT) is reported to be very low."/>
  <result pre="that is absorbed might undergo rapid methylation catalyzed by liver" exact="cytosolic" post="catechol-O-methyltransferase which decreases its hydrophilicity (Mereles &amp;amp; Hunstein, 2011),"/>
  <result pre="We attempted to explore this approach by screening selected natural" exact="secondary" post="metabolites for their dual binding potential to (1) viral"/>
  <result pre="natural secondary metabolites for their dual binding potential to (1)" exact="viral" post="main protease Mpro that has a conserved catalytic cleavage"/>
  <result pre="cleavage site responsible for post-translational processing of polyproteins required for" exact="viral" post="replication in all SARS corona viruses and (2) ACE2"/>
  <result pre="(2) ACE2 the principle receptor responsible for entry of the" exact="viral" post="particles into the host cells. The top four leads"/>
  <result pre="red pigmentation of pomegranate juice, are ingested orally. Nonetheless, their" exact="viral" post="inhibitory potential is greatly limited by low oral bioavailability."/>
  <result pre="are ingested orally. Nonetheless, their viral inhibitory potential is greatly" exact="limited" post="by low oral bioavailability. To overcome this bottleneck, these"/>
  <result pre="or can be encapsulated in nano/microparticles towards their site specific" exact="pulmonary" post="delivery. Acknowledgements PS is thankful for JRF fellowship received"/>
  <result pre="Pascual-TeresaS. (2014). Dietary gallic acid and anthocyanin cytotoxicity on human" exact="fibrosarcoma" post="HT1080 cells. A study on the mode of action."/>
  <result pre="ZhangP., &amp;amp; De SunW. (2018). Avicularin reversed multidrug-resistance in human" exact="gastric cancer" post="through enhancing Bax and BOK expressions. Biomedicine &amp;amp; Pharmacotherapyâ€‰=â€‰Biomedecine"/>
  <result pre="&amp;amp; De SunW. (2018). Avicularin reversed multidrug-resistance in human gastric" exact="cancer" post="through enhancing Bax and BOK expressions. Biomedicine &amp;amp; Pharmacotherapyâ€‰=â€‰Biomedecine"/>
  <result pre="(2019). Anthocyanins, delphinidin-3-O-glucoside and cyanidin-3-O-glucoside, inhibit immune checkpoints in human" exact="colorectal cancer" post="cells inÂ vitro and in silico. Scientific Reports, (1),"/>
  <result pre="Anthocyanins, delphinidin-3-O-glucoside and cyanidin-3-O-glucoside, inhibit immune checkpoints in human colorectal" exact="cancer" post="cells inÂ vitro and in silico. Scientific Reports, (1),"/>
  <result pre="J. (2003). Characterization of a novel coronavirus associated with severe" exact="acute" post="respiratory syndrome. Science, (5624), 1394â€&quot;1399. 10.1126/science.1085952 StenlidG. (1976). Effects"/>
  <result pre="(2003). Characterization of a novel coronavirus associated with severe acute" exact="respiratory" post="syndrome. Science, (5624), 1394â€&quot;1399. 10.1126/science.1085952 StenlidG. (1976). Effects of"/>
  <result pre="LuG., QiaoC., HuY., YuenK.-Y., WangQ., ZhouH., YanJ., &amp;amp; QiJ. (2020)." exact="Structural" post="and functional basis of SARS-CoV-2 entry by using human"/>
  <result pre="C., &amp;amp; ZhangY.-Z. (2020). A new coronavirus associated with human" exact="respiratory" post="disease in China. Nature, (7798), 265â€&quot;269. 10.1038/s41586-020-2008-3 YaoX., YeF.,"/>
  <result pre="&amp;amp; ZhangY.-Z. (2020). A new coronavirus associated with human respiratory" exact="disease" post="in China. Nature, (7798), 265â€&quot;269. 10.1038/s41586-020-2008-3 YaoX., YeF., ZhangM.,"/>
  <result pre="optimized dosing design of hydroxychloroquine for the treatment of severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2), 1â€&quot;8. Clinical Infectious Diseases."/>
  <result pre="dosing design of hydroxychloroquine for the treatment of severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2), 1â€&quot;8. Clinical Infectious Diseases. ."/>
  <result pre="design of hydroxychloroquine for the treatment of severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2), 1â€&quot;8. Clinical Infectious Diseases. . 10.1093/cid/ciaa237"/>
  <result pre="of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 1â€&quot;8. Clinical" exact="Infectious" post="Diseases. . 10.1093/cid/ciaa237 YuanY., CaoD., ZhangY., MaJ., QiJ., WangQ.,"/>
  <result pre="GuoH., JiangR.-D., LiuM.-Q., ChenY., ShenX.-R., WangX., â€¦ ShiZ.-L. (2020). A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="disposition of a pharmaceutical compound within an organism COVID-19 Coronavirus" exact="disease" post="2019 main protease (Mpro) a cysteine protease, the main"/>
  <result pre="main target for antiviral drugs against SARS and other coronavirus" exact="infections" post="Angiotensin-Converting Enzyme 2 (ACE2 a type I transmembrane metallocarboxypeptidase"/>
  <result pre="SARS and other coronavirus infections Angiotensin-Converting Enzyme 2 (ACE2 a" exact="type I" post="transmembrane metallocarboxypeptidase utilized by SARS-CoV-2 as a cellular entry"/>
  <result pre="and surface area, to enhance the binding affinity predictions severe" exact="acute" post="respiratory syndrome corona virus-2 (SARS-CoV-2) virus that cause COVID-19"/>
  <result pre="surface area, to enhance the binding affinity predictions severe acute" exact="respiratory" post="syndrome corona virus-2 (SARS-CoV-2) virus that cause COVID-19 disease"/>
  <result pre="area, to enhance the binding affinity predictions severe acute respiratory" exact="syndrome" post="corona virus-2 (SARS-CoV-2) virus that cause COVID-19 disease Swiss"/>
  <result pre="acute respiratory syndrome corona virus-2 (SARS-CoV-2) virus that cause COVID-19" exact="disease" post="Swiss ADME a tool to predict ADME parameters, pharmacokinetic"/>
 </snippets>
</snippetsTree>
